Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust Modestly Weighted Log-Rank Tests.

Pharmaceutical statistics·2025
Same author

Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary Endpoints.

Pharmaceutical statistics·2025
Same author

Visualizing hypothesis tests in survival analysis under anticipated delayed effects.

Pharmaceutical statistics·2024
Same author

The MaxCombo Test Severely Violates the Type I Error Rate.

JAMA oncology·2023
Same author

Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curves.

Biometrical journal. Biometrische Zeitschrift·2023
Same author

On model-based time trend adjustments in platform trials with non-concurrent controls.

BMC medical research methodology·2022
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Block response-adaptive randomization in clinical trials with binary endpoints.

Dominic Magirr1

  • 1Department of Mathematics and Statistics, Fylde College, Lancaster University, Lancaster, UK. d.magirr@lancaster.ac.uk

Pharmaceutical Statistics
|February 14, 2012
PubMed
Summary
This summary is machine-generated.

Response-adaptive randomization (RAR) improves clinical trials by favoring better treatments. Introducing random permuted blocks into RAR designs, like the randomized play-the-winner-rule, prevents problematic patient allocation sequences.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research Methodology

Background:

  • Response-adaptive randomization (RAR) aims to minimize patient failures by reallocating participants to more effective treatments during a trial.
  • Traditional RAR designs, such as the randomized play-the-winner-rule (RPWR), can exhibit myopic behavior, potentially leading to suboptimal randomization sequences.

Purpose of the Study:

  • To enhance existing response-adaptive randomization designs by incorporating random permuted blocks.
  • To mitigate the risk of unfavorable randomization sequences in clinical trials with binary endpoints.

Main Methods:

  • Introduced random permuted blocks into two RAR designs: randomized play-the-winner-rule (RPWR) and sequential maximum likelihood estimation.
  • Restricted allocation ratios within blocks to 1:1, 2:1, or 3:1 to ensure balanced and predictable assignments.
  • Conducted exact calculations to evaluate error rates and expected failures under various trial scenarios.

Main Results:

  • Block RAR designs demonstrated comparable reductions in expected failures to their non-blocked counterparts when compared to equal allocation.
  • The efficacy of block RAR in reducing failures was modest under the alternative hypothesis but significantly improved with larger treatment effects.
  • Prevented the occurrence of highly skewed or unfortunate randomization sequences observed in some traditional RAR methods.

Conclusions:

  • Random permuted blocks effectively enhance RAR designs, improving randomization sequence stability without compromising the ability to reduce patient failures.
  • These modified block RAR designs offer a more robust approach for clinical trials, particularly when a clinically relevant treatment effect is anticipated.
  • The integration of block randomization provides a practical solution to the myopic nature of some RAR methods, enhancing their real-world applicability.